virtual.MEDICA LABMED FORUM

12:00 – 13:00 h

Session: The microbiome, your second genome

12:00 – 12:05 h
Opening & Welcome: MEDICA LABMED FORUM, Monday
Tania Higgins (Moderator virtual.MEDICA)

12:05 – 12:12 h
Introduction: The microbiome, your second genome
Prof. Dr. med. Beniam Ghebremedhin, Universität Witten / Herdecke, HELIOS Universitätsklinikum Wuppertal

12:12 – 12:19 h
Overview in microbiome analysis
Prof. Dr. med. Dr. rer. nat. André Gessner, Universitätsklinikum Regensburg, Institut für Mikrobiologie und Hygiene

12:19 – 12:26 h
Microbiome and oncology research
Prof. Dr. med. Ernst Holler, Universitätsklinikum Regensburg, Transl. Forschung Hämato-Onkologie

12:26 – 12:33 h
The biochemical language of the microbiota-gut-brain axis
Dr. Jonathan Swann, Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London

12:33 – 12:40 h
The volatile organic compounds (VOCs) of gut microbiota in relation to exercise
Dr. Simona Cristescu, Institute for Molecules and Materials, Radboud University

12:40 – 13:00 h
Roundtable discussion



13:00 – 14:00 h

Session: Breathomics: Diagnostics from the air we breathe

13:00 – 13:07 h
Introduction: Breathomics: Diagnostics from the air we breathe
Prof. Dr. med. Beniam Ghebremedhin, Universität Witten/Herdecke, HELIOS Universitätsklinikum Wuppertal

13:07 – 13:14 h
Volatile organic compounds in gastrointestinal disorders
Dr. Agnieszka Smolinska, Pharmacology and Toxicology Department, Maastricht University

13:14 – 13:21 h
Ion mobility spectrometry in clinical microbiology
Dr. Wolfgang Vautz, ION-GAS GmbH, Dortmund

13:21 – 13:28 h
Shedding light on the biomolecular conversations between the gut microbiota and host using metabolomics
Dr. Jonathan Swann, Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London

13:28 – 13:35 h
VOC analysis and influenza virus infection
Prof. Dr. med. Wieland Voigt, MIM Steinbeis-Hochschule, Berlin

13:35 – 14:00 h
Roundtable discussion


[Version: 13 November 2020, subject to change]

12:00 – 13:00 h

Session: Cardiology goes digital

12:00 – 12:05 h
Opening & Welcome: MEDICA LABMED FORUM, Tuesday
Tania Higgins (Moderator virtual.MEDICA)

12:05 – 12:12 h
Introduction: Cardiology goes digital
Prof. Dr. med. Stefan Holdenrieder, Deutsches Herzzentrum München

12:12 – 12:19 h
DigiMed: Creating next level health care centers by data networks
Dr. med. Dr. med. Moritz von Scheidt, Deutsches Herzzentrum München

12:19 – 12:26 h
Digitalization in cardiac surgery
Prof. Dr. Markus Krane, Deutsches Herzzentrum München

12:26 – 12:33 h
Private data and lifestyle medicine
Prof. Dr. Billy Sperlich, Universität Würzburg

12:33 – 12:40 h
High-dimensional data: Make complexity simple
Prof. Dr. Frank Klawonn, HZI Braunschweig

12:40 – 13:00 h
Roundtable discussion



13:00 – 14:00 h

Session: Cancer diagnostics from blood

13:00 – 13:07 h
Introduction: Cancer diagnostics from blood
Prof. Dr. med. Stefan Holdenrieder, Deutsches Herzzentrum München

13:07 - 13:14 h
Cell-free DNA in solid cancer diagnostics
Dr. Frank Diehl, Hamburg

13:14 - 13:21 h
Routine use of artificial intelligence in molecular leukemia diagnostics
Niroshan Nadarajah, MLL Munich

13:21 – 13:28 h
Biology and clinical use of exosomes in oncology
Prof. Dr. Michiel Pegtel, University of Amsterdam

13:28 – 13:35 h
Stem cell derived EVs and immune regulatory functions
Prof. Dr. rer. nat Bernd Giebel, Institute for Transfusion Medicine, University Hospital of Essen

13:35 – 14:00 h
Roundtable discussion


[Version: 16 November 2020, subject to change]

12:00 – 13:00 h

Session: Diagnostic aspects and immunity

Chair: Prof. Dr. med. Gunther Hartmann, Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinikum Bonn


12:00 – 12:05 h
Opening & Welcome: MEDICA LABMED FORUM, Wednesday
Tania Higgins (Moderator virtual.MEDICA)

12:05 – 12:12 h
Introduction: diagnostic aspects and immunity
Prof. Dr. med. Gunther Hartmann, Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinikum Bonn

12:12 – 12:19 h
Current trends in SARS-CoV-2 testing
Prof. Dr. med. Hendrik Streeck, Universitätsklinikum Bonn

12:19 – 12:26 h
SARS-CoV-2 high-throughput testing
Prof. Dr. Jonathan Schmid-Burg, Universitätsklinikum Bonn

12:26 – 12:33 h
External ring trials for SARS-CoV-2 antibodies
Dr. med. Verena Haselmann, Universitätsmedizin Mannheim

12:33 – 12:40 h
Diagnostic performance of PCR and antibody assays in an outbreak situation
Dr. med. Alexander von Meyer, Medizet (Medical Service Centre), Munich Clinic

12:40 – 13:00 h
Roundtable discussion

13:00 – 14:00 h

Session: Clinical aspects

Chair: Prof. Dr. med. Stefan Holdenrieder, Deutsches Herzzentrum München


13:00 – 13:07 h
Introduction: COVID-19 clinical aspects
Prof. Dr. med. Stefan Holdenrieder, Deutsches Herzzentrum München

13:07 – 13:14 h
Immunity against CoV-2
Prof. Dr. med. Gunther Hartmann, Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinikum Bonn

13:14 – 13:21 h
Vaccination strategies against SARS-CoV-2
Prof. Dr. med. Gunther Hartmann, Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinikum Bonn

13:21 – 13:28 h
COVID-19-induced coagulopathy
Prof. Dr. med. Bernd Poetzsch, Universitätsklinikum Bonn

13:28 – 13:35 h
Genetic predisposition for COVID-19 susceptibility
Dr. med. Hanns-Georg Klein, MVZ Martiensried

13:35 – 13:42 h
How to predict the potential overload of health systems by COVID-19
Prof. Dr. Frank Klawonn, HZI Braunschweig

13:42 – 14:00 h
Roundtable discussion

[Version: 16 November 2020, subject to change]

12:00 – 13:00 h

Session: Young talents in diagnostics and research

Chair: Dr. med. Verena Haselmann, Universitätsmedizin Mannheim


12:00 – 12:05 h
Opening & Welcome: MEDICA LABMED FORUM, Thursday
Tania Higgins (Moderator virtual.MEDICA)

12:05 – 12:10 h
Introduction: Young talents in diagnostics and research
Dr. med. Verena Haselmann, Universitätsmedizin Mannheim

12:10 – 12:15 h
Assays for SARS-CoV-2 antibodies
Dr. Ronald Biemann, Universitätsklinikum Leipzig

12:15 – 12:20 h
Antimicrobial peptides in septic arthritis
Dr. Dzemal Elezagic, Uniklinik Köln

12:20 – 12:25 h
Discussion

12:25 – 12:30 h
ProBNP in children with inborn heart defects
Jonas Palm, Deutsches Herzzentrum München

12:30 – 12:35 h
Innovative visualization of clinical and laboratory data
Dr. med. Margot Thiaucourt, Universitätsmedizin Mannheim

12:35 – 12:40 h
Discussion

12:40 – 12:45 h
cfDNA in cancer
Romina Rösch, Technische Universität München

12:45 – 12:50 h
Tumor heterogeneity in daily practice
Zsolt Kovac, Universität Bonn

12:50 – 12:55 h
LAGGO - Laboratory Assessment of Ground Glass Opacities 
Catharina Gerhards

12:55 – 13:00 h
Discussion



13:00 – 14:00 h

Session: Innovative COVID-19 diagnostics

Chair: Dr. Peter Quick, Promega GmbH & Vorstandsvorsitzender der Fachabteilung Life Science Research (FA LSR) im Verband der Diagnostica-Industrie (VDGH)


13:00 – 13:05 h
Introduction: Innovative COVID-19 diagnostics
Dr. Peter Quick, Promega GmbH & Vorstandsvorsitzender der Fachabteilung Life Science Research (FA LSR) im Verband der Diagnostica-Industrie (VDGH)

13:05 – 13:12 h
Circulating nucleosomes as potential prognostic markers for COVID-19 disease severity
Dr. Mark Eccleston, Business Development Director, VolitionRX

13:12 – 13:19 h
Decoding epigenetics and its implications for the immune response to COVID-19
Dr. Moritz Völker-Albert, EpiQMAx GmbH

13:19 – 13:26 h
Lumit™ Dx SARS-CoV-2 assay technology
Torben Wolf, Promega GmbH

13:26 – 13:33 h
Disposable sensors for on-site COVID-19 testing
Dr.-Ing. Can Dincer, IMTEK - Lab for Sensors

13:33 – 13:40 h
Rapid AI based COVID-19 assay development
Dr. Markus Seifert, Seegene Germany GmbH

13:40 – 13:47 h
Novel Macroarray and RBD-specific ELISA for the detection of SARS-CoV-2-specific antibodies
Dr. rer. nat. Mathias Schlegel, Seramun Diagnostica GmbH

13:47 – 13:54 h
New drugs targeting two essential and novel molecular targets in SARS-CoV-2
Dr. Adrian Schomburg, Eisbach Bio GmbH

13:54 – 14:00 h
Closing: Innovative COVID-19 diagnostics
Dr. Peter Quick, Promega GmbH & Vorstandsvorsitzender der Fachabteilung Life Science Research (FA LSR) im Verband der Diagnostica-Industrie (VDGH)


[Version: 17 November 2020, subject to change]